Carbetapentane tannate 30 mg / diphenhydrAMINE tannate 25 mg / phenylephrine tannate 10 mg Extended Release Oral Tablet
RxNorm 1294371
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1294371 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbetapentane tannate 30 mg / diphenhydrAMINE tannate 25 mg / phenylephrine tannate 10 mg Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbetapentane tannate 30 mg / diphenhydramine tannate 25 mg / phenylephrine tannate 10 mg Extended Release Oral Tablet
(Atom ID: 12349103)
PSN
Prescribable Name (PSN):
Carbetapentane tannate 30 mg / diphenhydrAMINE tannate 25 mg / phenylephrine tannate 10 mg Extended Release Oral Tablet
(Atom ID: 6366433)
TMSY